CCT5 and cancer: The CpG-aggregated methylation analysis of CCT5 in human cancers demonstrated that the methylation level of CCT5 was lower in BLCA, BRCA, CESC, COAD, ESCA, KIRC, LIHC, LUAD, LUSC, PRAD, READ, and UCEC (Fig. 4C).